{"gene":"L1CAM","run_date":"2026-06-10T02:59:49","timeline":{"discoveries":[{"year":1994,"finding":"Mutations in the L1CAM gene cause X-linked hydrocephalus (HSAS), MASA syndrome, and SPG1, demonstrating that L1CAM protein function is essential for nervous system development; two HSAS mutations were identified that abolish cell surface expression of L1CAM, representing functional null mutations.","method":"Mutational analysis in patient cohorts; functional assessment of cell surface expression loss","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated across multiple disease families, multiple orthogonal methods (sequencing + functional cell surface expression assessment), independently confirmed in subsequent studies","pmids":["7920659"],"is_preprint":false},{"year":2009,"finding":"L1CAM undergoes sequential proteolytic processing: first, ADAM10 cleaves L1CAM at the membrane to generate an L1-32 fragment; then presenilin/gamma-secretase performs regulated intramembrane proteolysis to release a 28 kDa intracellular domain (L1-ICD) that translocates to the nucleus and mediates gene regulation. Inhibition of either ADAM10 or gamma-secretase blocks nuclear translocation and L1-dependent gene regulation.","method":"Dominant-negative PS1 overexpression, gamma-secretase inhibitors, fluorescence and biochemical fractionation, recombinant L1-ICD overexpression in carcinoma cells","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal methods (pharmacological inhibition, dominant-negative, biochemical fractionation, overexpression) in single lab establishing cleavage mechanism","pmids":["19260824"],"is_preprint":false},{"year":2011,"finding":"L1CAM regulates DNA damage checkpoint responses and radioresistance of glioblastoma stem cells through nuclear translocation of the L1-ICD, which upregulates NBS1 expression via c-Myc, thereby enhancing MRE11-RAD50-NBS1 (MRN) complex activity and ATM-Chk2 checkpoint signaling. Ectopic NBS1 expression rescued checkpoint activation lost upon L1CAM knockdown.","method":"RNA interference knockdown, ectopic NBS1 rescue experiments, checkpoint activation assays, nuclear translocation analysis in glioblastoma stem cells","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (RNAi, rescue, pathway analysis) in single lab with rigorous epistasis experiment","pmids":["21297581"],"is_preprint":false},{"year":2007,"finding":"L1CAM expression in colon cancer cells confers metastatic capacity and induces liver metastasis in a mouse spleen-injection model. ADAM10, identified as a novel beta-catenin-TCF target gene, cleaves the L1CAM extracellular domain and enhances metastasis. L1CAM induces a specific gene program in colon cancer cells also elevated in human colorectal carcinoma tissue.","method":"Stable transfection of L1CAM in colon cancer cells, in vivo mouse liver metastasis assay, ADAM10 overexpression, DNA microarray analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo and in vitro functional assays with multiple cell lines, replicated across conditions with mechanistic follow-up","pmids":["17699774"],"is_preprint":false},{"year":2006,"finding":"MAP kinase pathway-dependent phosphorylation of the FIGQY motif in the L1CAM cytoplasmic domain regulates its interaction with ankyrin B, and this modulation of ankyrin binding controls L1CAM-mediated neuronal growth. MAP kinase pathway inhibitors block L1CAM-mediated neuronal growth, and this blockade is partially rescued by inhibitors of L1CAM-ankyrin binding.","method":"Intramolecular BRET reporter assay for FIGQY phosphorylation, MAP kinase pathway inhibitors, ankyrin binding inhibitors, neuronal growth assays","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — novel BRET-based reporter plus pharmacological epistasis, multiple orthogonal methods establishing phosphorylation-dependent ankyrin binding as regulatory mechanism","pmids":["16597699"],"is_preprint":false},{"year":2012,"finding":"L1CAM promotes neurite outgrowth by directly binding microtubule-associated protein 2c (MAP2c) via its intracellular domain (as shown by ELISA binding assay), and by enhancing MAP2 expression through the MAPK pathway. L1-deficient mice show reduced MAP2c levels; combined deficiency in both L1 and MAP2 reduces neurite outgrowth in vitro.","method":"ELISA binding assay (direct binding of MAP2c to L1 intracellular domain), co-immunoprecipitation of MAP2 isoforms with L1, L1-knockout mice, MAPK inhibitors, in vitro neurite outgrowth assays","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct in vitro binding assay plus co-IP plus genetic loss-of-function with clear phenotypic readout","pmids":["22503709"],"is_preprint":false},{"year":2012,"finding":"L1CAM physically binds ErbB receptors (including erbB1/EGFR) through Ig-like domains in its extracellular region, and this interaction enhances erbB receptor response to neuregulins. L1CAM-erbB binding was demonstrated in heterologous systems and in the mammalian developing brain.","method":"Co-immunoprecipitation in heterologous systems and developing brain tissue, binding domain mapping with Ig-like domain constructs","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP in multiple systems (heterologous + brain tissue) with functional neuregulin response assay, single lab","pmids":["22815787"],"is_preprint":false},{"year":2010,"finding":"L1cam acts as a modifier gene in enteric nervous system development: loss of L1cam combined with heterozygous Sox10 loss significantly increases the incidence of aganglionosis by perturbing neural crest cell migration in the gut and causing excessive neural crest cell death prior to gut entry. Sox10 regulates L1cam expression.","method":"Two-locus complementation genetic crosses (L1cam knockout × Ret, Gdnf, Sox10 heterozygotes), in vivo aganglionosis scoring, neural crest cell migration analysis, cell death quantification","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Moderate — classical genetic epistasis with two-locus complementation, rigorous in vivo phenotypic readout, mechanistic follow-up showing migration defects and cell death","pmids":["20696247"],"is_preprint":false},{"year":2010,"finding":"L1CAM is ubiquitinated at the plasma membrane and in early endosomes; mono-ubiquitination enhances its lysosomal degradation and regulates intracellular trafficking, thereby controlling L1CAM re-appearance at the cell surface.","method":"Biochemical ubiquitination assays, subcellular fractionation, lysosomal degradation inhibitors, trafficking analysis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct biochemical demonstration of ubiquitination plus lysosomal degradation assay, single lab","pmids":["20940017"],"is_preprint":false},{"year":2012,"finding":"L1CAM stimulates glioma cell motility and proliferation through fibroblast growth factor receptor (FGFR) activation. Soluble L1 ectodomain (L1LE) acts as a ligand for FGFR1 on glioma cells; dominant-negative FGFR1 or L1 peptide blocking L1-FGFR interaction abolished glioma cell migration; combined shutdown of L1 expression and FGFR activity completely terminated cell migration in vitro.","method":"Dominant-negative FGFR1, shRNA knockdown of L1, L1-FGFR interaction-blocking peptide, FGFR1 chemical inhibitor PD173074, time-lapse motility assays, cell cycle analysis","journal":"Clinical & experimental metastasis","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (dominant-negative, RNAi, blocking peptide, chemical inhibitor) converging on L1-FGFR1 interaction as mechanistic basis, single lab","pmids":["23212305"],"is_preprint":false},{"year":2019,"finding":"ADAM10-mediated shedding of L1cam is regulated by its fibronectin type III (FNIII) domains; specifically, the third FNIII domain maintains a conformation restricting access to the membrane-proximal cleavage site. Metalloproteinase-mediated shedding is required for efficient myelination but not for axonal outgrowth or ventricular system development, as shown by rescue experiments with proteinase-resistant and soluble L1cam variants in zebrafish.","method":"Zebrafish l1camb knockdown, rescue experiments with proteinase-resistant and soluble L1cam variants, in vivo axonal outgrowth and myelination phenotype analysis","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — domain-specific mutant rescue experiments in vivo with clear differential phenotypic readouts for distinct developmental processes","pmids":["30842511"],"is_preprint":false},{"year":2019,"finding":"Endothelial cells express a novel L1CAM isoform (L1-ΔTM) lacking the transmembrane domain, generated by NOVA2 splicing factor-mediated skipping of the transmembrane domain exon. L1-ΔTM is secreted as a soluble protein that promotes angiogenesis through FGFR1 signaling via autocrine and paracrine activities.","method":"Alternative splicing analysis, NOVA2 knockdown/overexpression, direct NOVA2 binding to L1CAM pre-mRNA, FGFR1 inhibition assays, in vivo angiogenesis models, ovarian cancer vasculature analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mechanistic dissection of splicing regulation (direct NOVA2-pre-mRNA binding), functional FGFR1 signaling rescue assays, in vivo validation, multiple orthogonal methods","pmids":["30829570"],"is_preprint":false},{"year":2017,"finding":"L1CAM promotes oncogenicity in esophageal squamous cell carcinoma by upregulating ezrin expression through activation of integrin α5β1/MAPK/ERK/AP1 signaling. L1CAM knockdown decreased cell growth, migration, and invasiveness, while overexpression had opposite effects; ezrin was identified as a key downstream effector.","method":"L1CAM knockdown and overexpression, in vitro and in vivo tumorigenesis assays, gene expression microarray/GSEA analysis, mechanistic pathway inhibition studies","journal":"Journal of molecular medicine (Berlin, Germany)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss and gain of function with in vivo validation plus pathway analysis, single lab","pmids":["28939985"],"is_preprint":false},{"year":2017,"finding":"Fibroblast-expressed L1CAM, induced by Mint3-mediated HIF-1 activation, stimulates ERK signaling via integrin α5β1 in adjacent cancer cells, promoting cancer cell proliferation in a cell-cell contact-dependent manner and enhancing tumor growth in vivo.","method":"Mint3 depletion in mouse embryonic fibroblasts, co-injection tumor assays in mice, gene expression analysis, L1CAM knockdown, pathway inhibition","journal":"Oncogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro functional assays with mechanistic pathway placement, single lab","pmids":["28504692"],"is_preprint":false},{"year":2021,"finding":"L1CAM promotes ovarian cancer stemness and tumor initiation by physically interacting with and activating FGFR1, which in turn induces SRC-mediated STAT3 activation. STAT3 inhibition prevented L1CAM-dependent stemness and tumor initiation; an L1CAM-neutralizing antibody blocked these activities.","method":"Co-immunoprecipitation of L1CAM-FGFR1 complex, STAT3 inhibition rescue assays, gain/loss-of-function in patient-derived cancer stem cells, in vivo tumor initiation assays, antibody-mediated neutralization","journal":"Journal of experimental & clinical cancer research : CR","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct protein-protein interaction (Co-IP) plus epistatic rescue experiments plus in vivo validation with multiple orthogonal approaches, single lab","pmids":["34645505"],"is_preprint":false},{"year":2011,"finding":"Full-length L1CAM (FL-L1CAM), but not the tumor-associated splice variant lacking exons 2 and 27 (SV-L1CAM), promotes experimental lung and liver metastasis. FL-L1CAM correlates with increased invasive potential and elevated MMP-2 and MMP-9 expression and activity.","method":"Selective overexpression of each isoform in tumor cells, in vivo mouse metastasis assays (lung/liver), MMP activity assays (zymography), in vitro invasion assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific overexpression with in vivo metastasis assays and biochemical MMP activity measurement, single lab","pmids":["21541352"],"is_preprint":false},{"year":2021,"finding":"CWH43 deletion decreases N-glycosylation of L1CAM, reduces its association with cell membrane lipid microdomains, increases L1CAM cleavage by plasmin, and increases shedding of cleaved L1CAM in cerebrospinal fluid. CWH43 deletion also decreased L1CAM nuclear translocation, suggesting decreased intracellular signaling.","method":"CWH43 mutant mice and human HeLa cells with CWH43 deletion, N-glycosylation analysis, lipid microdomain fractionation, plasmin cleavage assays, CSF L1CAM measurement, nuclear translocation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biochemical methods in both mouse model and human cells, single lab","pmids":["34380733"],"is_preprint":false},{"year":2014,"finding":"L1cam is required for cell locomotion in the intermediate zone and terminal translocation of the soma through the primitive cortical zone during radial migration in murine corticogenesis. L1cam-knockdown neurons showed decreased locomotion velocity, longer and more undulated leading processes, and decreased somal movement during terminal translocation.","method":"In utero electroporation of shRNA targeting L1cam, time-lapse analysis of neuronal migration in brain slices, quantitative curvature index analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo knockdown with live time-lapse imaging and quantitative phenotypic analysis, single lab","pmids":["24489698"],"is_preprint":false},{"year":2019,"finding":"L1CAM-decorated exosomes stimulate glioblastoma cell motility, proliferation, and invasiveness. The motility and proliferation-promoting effects of L1-decorated exosomes are reduced by inhibitors of focal adhesion kinase (FAK) and fibroblast growth factor receptor (FGFR), placing L1CAM action upstream of these kinases.","method":"Exosome isolation and L1CAM decoration characterization, SuperScratch motility assay, DNA cell cycle analysis, chick embryo brain tumor invasion model, FAK and FGFR chemical inhibitors","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional assays with inhibitor pathway placement, single lab, multiple cell systems tested","pmids":["31426278"],"is_preprint":false},{"year":2008,"finding":"L1CAM expression on tumor-derived endothelial cells is upregulated by TNF-α, IFN-γ, and TGF-β1. L1CAM on endothelium mediates selective tumor cell adhesion and transendothelial migration; antibodies to L1CAM and its ligand neuropilin-1 blocked tube formation and SDF-1β-induced transmigration of tumor endothelial cells.","method":"Cytokine stimulation of endothelial cells, anti-L1CAM and anti-neuropilin-1 antibody blocking assays, tube formation assay, transmigration assay, tumor cell adhesion to endothelial monolayers","journal":"Journal of molecular medicine (Berlin, Germany)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional blocking antibody experiments with multiple assays establishing L1CAM role in transendothelial migration, single lab","pmids":["18931829"],"is_preprint":false},{"year":2022,"finding":"L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary: L1CAM upregulates integrins and fibronectin in malignant cells and activates AKT and ERK pathways, increasing cell survival under anchorage-independent conditions and enabling cohesive invasion of the ovary.","method":"L1CAM gain/loss-of-function in fallopian tube secretory cells, tumor-ovary co-culture invasion model, pathway analysis (AKT, ERK activation), anchorage-independent survival assays","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — novel co-culture model, genetic manipulation with multiple functional and signaling readouts, single lab","pmids":["36509990"],"is_preprint":false},{"year":2023,"finding":"Alpha-synuclein promotes L1CAM expression and localization to the plasma membrane by protecting L1CAM from lysosomal degradation. Knockout of SNCA in melanoma cells led to a 75% reduction in motility and significant decreases in L1CAM and N-cadherin expression; the reduction in L1CAM was not due to transcriptional effects but rather increased lysosomal degradation of L1CAM.","method":"SNCA knockout by CRISPR in melanoma cell lines, stable SNCA overexpression in neuroblastoma cells, motility assays, lysosomal degradation assays, mRNA and protein expression analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss and gain of function with mechanistic follow-up (lysosomal degradation assay), single lab","pmids":["37286800"],"is_preprint":false},{"year":2018,"finding":"L1CAM is induced during cellular senescence by TGFβ signaling and is suppressed by RAS/MAPK(Erk) signaling; it is also induced by p16INK4a-mediated CDK inhibition. Senescent cells with enhanced surface L1CAM showed increased adhesion to extracellular matrix and faster migration.","method":"Proteome profiling of senescent cells, pharmacological induction of senescence, TGFβ treatment, Ras expression, p16INK4a modulation, cell adhesion and migration assays","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological and genetic perturbations with functional adhesion/migration readouts, single lab","pmids":["29615539"],"is_preprint":false},{"year":2018,"finding":"L1-CAM undergoes grip and slip states on adhesive substrates; the ratio of grip state is higher on laminin than on polylysine, accompanied by increased traction force. Asymmetric grip/slip of L1-CAM under the growth cone generates directional force for laminin-induced haptotaxis. This mechanism is disrupted in an L1CAM syndrome patient with corpus callosum agenesis.","method":"Single-molecule imaging of L1-CAM on growth cones, traction force microscopy, laminin vs polylysine substrate comparison, patient-derived cell analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — single-molecule imaging with traction force microscopy establishing biophysical mechanism, disease validation in patient cells","pmids":["29483251"],"is_preprint":false},{"year":2024,"finding":"KLF12 binds directly to the L1CAM promoter and represses its transcription; TRIM27 ubiquitinates KLF12 at K326 via K33-linked polyubiquitination, reducing KLF12 transcriptional activity and consequently increasing L1CAM expression. Depletion of L1CAM abrogates cisplatin resistance and cancer metastasis caused by KLF12 loss in esophageal squamous cell carcinoma.","method":"Chromatin immunoprecipitation (ChIP) assay showing KLF12 binding to L1CAM promoter, ubiquitination site mapping (K326), rescue experiments with L1CAM depletion, cisplatin resistance and metastasis assays","journal":"Drug resistance updates","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ChIP evidence for promoter binding, ubiquitination site identification, functional rescue, single lab","pmids":["38924996"],"is_preprint":false},{"year":2024,"finding":"The ADAMTS1 metalloprotease activates an ADAMTS1-L1CAM-EGFR signaling axis in oral squamous cell carcinoma: ADAMTS1 increases L1CAM levels, which activates EGFR, leading to EMT and enhanced invasiveness and lymph node metastasis.","method":"ADAMTS1 knockdown and overexpression in OSCC cells and xenografts, in vivo lymph node metastasis assay, mechanistic pathway analysis (EGFR activation, EMT markers), pharmacological inhibition by apigenin","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo xenograft model with genetic manipulation and pathway analysis, single lab","pmids":["38263290"],"is_preprint":false},{"year":1991,"finding":"Human L1CAM supports neurite growth in vitro and shows 92% amino acid identity to mouse L1cam. Comparison across species identifies the second Ig domain and second fibronectin type III domain as the most conserved and likely functionally important domains.","method":"Neurite growth assay on human L1CAM substrate, full coding region cloning and sequencing, cross-species sequence comparison","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional neurite growth assay combined with sequence analysis, foundational study","pmids":["1769655"],"is_preprint":false},{"year":2020,"finding":"L1cam deletion in adult hippocampal stem/progenitor cells increases differentiation of progenitors into new neurons, increases dendritic arbor complexity in immature neurons, and accelerates age-related decline in hippocampal neurogenesis; deletion in neurons leads to increased anxiety-related behavior.","method":"Conditional knockout using multiple Cre-driver lines in mice, BrdU/EdU lineage tracing, morphological analysis of dendritic complexity, behavioral assays","journal":"Stem cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional genetic deletion with multiple Cre lines and multiple readouts, single lab","pmids":["32971459"],"is_preprint":false},{"year":1998,"finding":"A silent C924T mutation (G308G) in exon 8 of L1CAM creates a novel 5' splice site, resulting in an in-frame deletion of 69 bp (23 amino acids) from exon 8, causing X-linked hydrocephalus. RT-PCR of affected fetal RNA confirmed aberrant splicing.","method":"DNA sequencing, splice site consensus sequence analysis, RT-PCR of affected fetal RNA confirming in-frame deletion","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RT-PCR confirmation of predicted aberrant splicing in patient-derived RNA, establishing mechanism for a synonymous mutation","pmids":["9643285"],"is_preprint":false}],"current_model":"L1CAM is a multifunctional immunoglobulin superfamily cell adhesion molecule that mediates homophilic and heterophilic cell-cell adhesion through its extracellular Ig and fibronectin type III domains, binds ErbB receptors and FGFR to activate downstream MAPK/ERK and PI3K/AKT signaling, undergoes regulated intramembrane proteolysis by ADAM10 then presenilin/gamma-secretase to release a nuclear-signaling intracellular domain (L1-ICD) that upregulates target genes (including NBS1 via c-Myc), is regulated post-translationally by ubiquitination (promoting lysosomal degradation), MAP kinase-dependent FIGQY phosphorylation (controlling ankyrin B binding and cytoskeletal linkage), N-glycosylation (affecting lipid microdomain association and susceptibility to plasmin cleavage), and alpha-synuclein-dependent lysosomal trafficking; it promotes neuronal migration, axon growth, and myelination (with shedding specifically required for myelination but not axonal outgrowth), and in cancer drives invasion, metastasis, chemoresistance, and stemness primarily through integrin (α5β1, αvβ3/αvβ5), FGFR1, and EGFR signaling, with transcription regulated by Wnt/β-catenin-TCF, androgen receptor, KLF12/TRIM27, and TGFβ pathways."},"narrative":{"mechanistic_narrative":"L1CAM is an immunoglobulin-superfamily cell adhesion molecule essential for nervous system development, where its function is required for neuronal migration, axon growth, and myelination, and whose loss-of-function mutations cause X-linked hydrocephalus, MASA syndrome, and SPG1 [PMID:7920659, PMID:24489698, PMID:30842511]. At the growth cone, L1CAM transduces adhesion into directional motility through asymmetric grip/slip dynamics on laminin that generate traction force for haptotaxis [PMID:29483251], and it couples to the cytoskeleton via MAP-kinase-dependent phosphorylation of its cytoplasmic FIGQY motif, which controls ankyrin B binding and neuronal growth, and via direct binding to MAP2c through its intracellular domain [PMID:16597699, PMID:22503709]. L1CAM is processed by sequential proteolysis: ADAM10 sheds the ectodomain and presenilin/gamma-secretase then liberates a nuclear L1-ICD that drives gene regulation, including upregulation of NBS1 via c-Myc to enhance MRN-dependent ATM-Chk2 checkpoint signaling and radioresistance [PMID:19260824, PMID:21297581]; this shedding, restricted by the third fibronectin type III domain, is specifically required for myelination but not axonal outgrowth [PMID:30842511]. Surface levels of L1CAM are controlled post-translationally by mono-ubiquitination-driven lysosomal degradation, by N-glycosylation that governs lipid-microdomain association and plasmin susceptibility, and by alpha-synuclein-dependent protection from lysosomal turnover [PMID:20940017, PMID:34380733, PMID:37286800]. In cancer, L1CAM and its shed/soluble ectodomain drive invasion, metastasis, stemness, and chemoresistance by acting as a ligand for FGFR1 (engaging SRC-STAT3 and FAK) and by activating integrin alpha5beta1 and EGFR signaling through ERK/AKT, with transcription regulated by beta-catenin-TCF-induced ADAM10, KLF12/TRIM27, ADAMTS1, and TGFbeta inputs [PMID:17699774, PMID:23212305, PMID:34645505, PMID:28939985, PMID:38924996, PMID:38263290].","teleology":[{"year":1991,"claim":"Established human L1CAM as a functional neurite-growth-promoting adhesion molecule and pinpointed the most conserved Ig and FNIII domains as candidate functional regions.","evidence":"Neurite growth assay on human L1CAM substrate plus cross-species sequence comparison","pmids":["1769655"],"confidence":"Medium","gaps":["Did not define the binding partners engaged by the conserved domains","Functional importance inferred from conservation, not direct mutagenesis"]},{"year":1994,"claim":"Demonstrated that L1CAM function is essential for human nervous system development by linking loss-of-function mutations to X-linked hydrocephalus, MASA, and SPG1.","evidence":"Mutational analysis in patient cohorts with functional cell-surface expression assays","pmids":["7920659"],"confidence":"High","gaps":["Did not resolve which downstream molecular activities of L1CAM are lost in disease","Genotype-phenotype relationships across syndromes not mechanistically explained"]},{"year":1998,"claim":"Showed that even a synonymous coding change can disrupt L1CAM by creating a cryptic splice site, broadening the mutational mechanisms causing hydrocephalus.","evidence":"DNA sequencing and RT-PCR of affected fetal RNA confirming in-frame exon 8 deletion","pmids":["9643285"],"confidence":"Medium","gaps":["Functional consequence of the 23-amino-acid deletion on protein folding/adhesion not tested","Single mutation; generalizability unknown"]},{"year":2006,"claim":"Connected extracellular signaling to cytoskeletal coupling by showing MAP-kinase-dependent FIGQY phosphorylation controls ankyrin B binding and thereby L1CAM-mediated neuronal growth.","evidence":"Intramolecular BRET phosphorylation reporter, MAP kinase and ankyrin-binding inhibitors, neuronal growth assays","pmids":["16597699"],"confidence":"High","gaps":["Identity of the kinase acting directly on FIGQY not established","Rescue by ankyrin-binding inhibitors only partial, implying additional effectors"]},{"year":2007,"claim":"Placed L1CAM in a Wnt-driven metastatic program, identifying ADAM10 as a beta-catenin-TCF target that sheds L1CAM and enhances colon cancer liver metastasis.","evidence":"Stable L1CAM transfection, in vivo mouse liver metastasis, ADAM10 overexpression, microarray analysis","pmids":["17699774"],"confidence":"High","gaps":["The receptor(s) transducing the pro-metastatic L1CAM signal not defined here","Causal contribution of shedding vs full-length L1CAM to metastasis not separated"]},{"year":2008,"claim":"Revealed an endothelial role for L1CAM in tumor vasculature, mediating tumor-cell adhesion and transendothelial migration via neuropilin-1.","evidence":"Cytokine stimulation, anti-L1CAM and anti-neuropilin-1 blocking antibodies, tube formation and transmigration assays","pmids":["18931829"],"confidence":"Medium","gaps":["Direct L1CAM-neuropilin-1 binding not biochemically demonstrated","In vivo relevance to metastasis not tested"]},{"year":2009,"claim":"Defined the regulated intramembrane proteolysis cascade (ADAM10 then gamma-secretase) that releases a nuclear-signaling L1-ICD, establishing L1CAM as a source of nuclear gene-regulatory signaling.","evidence":"Dominant-negative PS1, gamma-secretase inhibitors, biochemical fractionation, recombinant L1-ICD overexpression in carcinoma cells","pmids":["19260824"],"confidence":"High","gaps":["Direct transcriptional targets of L1-ICD not identified in this study","Mechanism of L1-ICD nuclear import not resolved"]},{"year":2010,"claim":"Demonstrated post-translational control of L1CAM surface availability through mono-ubiquitination-driven lysosomal degradation and trafficking.","evidence":"Biochemical ubiquitination assays, subcellular fractionation, lysosomal inhibitors, trafficking analysis","pmids":["20940017"],"confidence":"Medium","gaps":["The E3 ligase responsible was not identified","Physiological/disease contexts regulating this turnover not defined"]},{"year":2010,"claim":"Identified L1cam as a Sox10-regulated modifier gene in enteric nervous system development, controlling neural crest migration and survival.","evidence":"Two-locus complementation crosses (L1cam x Sox10/Ret/Gdnf heterozygotes), aganglionosis scoring, migration and cell-death analysis","pmids":["20696247"],"confidence":"High","gaps":["Molecular mechanism linking L1cam to crest cell survival not defined","Direct evidence for Sox10 acting on the L1cam promoter not shown here"]},{"year":2011,"claim":"Connected nuclear L1-ICD signaling to DNA-damage checkpoint control, showing it upregulates NBS1 via c-Myc to drive MRN/ATM-Chk2 signaling and radioresistance in glioblastoma stem cells.","evidence":"RNAi knockdown, ectopic NBS1 rescue, checkpoint activation assays in glioblastoma stem cells","pmids":["21297581"],"confidence":"High","gaps":["Direct DNA binding of L1-ICD vs indirect action via c-Myc not fully resolved","Generality beyond glioblastoma stem cells untested"]},{"year":2011,"claim":"Distinguished isoform-specific oncogenic activity, showing full-length but not the exon-2/27-deleted splice variant promotes metastasis via elevated MMP-2/MMP-9.","evidence":"Isoform-specific overexpression, in vivo lung/liver metastasis assays, zymography, invasion assays","pmids":["21541352"],"confidence":"Medium","gaps":["Mechanism by which deleted exons abolish activity not defined","Receptor coupling to MMP induction not mapped"]},{"year":2012,"claim":"Identified FGFR1 as a receptor for the soluble L1 ectodomain driving glioma motility and proliferation, establishing a ligand-receptor mode of L1CAM action distinct from adhesion.","evidence":"Dominant-negative FGFR1, shRNA, L1-FGFR blocking peptide, PD173074, time-lapse motility and cell-cycle assays","pmids":["23212305"],"confidence":"High","gaps":["Stoichiometry/structure of the L1-FGFR1 interaction not defined","Downstream signaling branches not fully mapped in this study"]},{"year":2012,"claim":"Showed L1CAM physically binds ErbB/EGFR receptors via Ig domains and potentiates neuregulin responses, broadening its receptor crosstalk repertoire.","evidence":"Reciprocal Co-IP in heterologous systems and developing brain, Ig-domain mapping, neuregulin response assays","pmids":["22815787"],"confidence":"Medium","gaps":["Functional consequence in vivo development not established","Direct vs complex-mediated binding not fully resolved"]},{"year":2012,"claim":"Demonstrated L1CAM promotes neurite outgrowth via direct intracellular binding to MAP2c and MAPK-dependent MAP2 induction, linking adhesion to microtubule organization.","evidence":"ELISA direct-binding assay, Co-IP, L1-knockout mice, MAPK inhibitors, neurite outgrowth assays","pmids":["22503709"],"confidence":"High","gaps":["Binding interface on the L1 intracellular domain not mapped","Relative contributions of direct binding vs MAP2 induction not quantified"]},{"year":2014,"claim":"Defined the cell-biological role of L1cam in radial migration, required for intermediate-zone locomotion and terminal somal translocation during corticogenesis.","evidence":"In utero electroporation of shRNA, time-lapse imaging in brain slices, quantitative morphometry","pmids":["24489698"],"confidence":"Medium","gaps":["Molecular effectors coupling L1cam to soma movement not identified","Single-gene knockdown; modifier interactions not examined"]},{"year":2017,"claim":"Established integrin alpha5beta1/MAPK/ERK/AP1 as an L1CAM oncogenic pathway driving ezrin expression in esophageal squamous cell carcinoma.","evidence":"L1CAM knockdown/overexpression, in vitro/in vivo tumorigenesis, GSEA, pathway inhibition","pmids":["28939985"],"confidence":"Medium","gaps":["Direct L1CAM-integrin engagement not biochemically shown","Role of ezrin as the sole effector not exclusive"]},{"year":2017,"claim":"Revealed a paracrine mechanism in which fibroblast-expressed L1CAM, driven by Mint3/HIF-1, stimulates integrin alpha5beta1/ERK signaling in adjacent cancer cells.","evidence":"Mint3 depletion in MEFs, co-injection tumor assays, L1CAM knockdown, pathway inhibition","pmids":["28504692"],"confidence":"Medium","gaps":["Contact-dependent ligand-receptor identity not biochemically confirmed","Relevance to human stromal contexts not tested"]},{"year":2018,"claim":"Provided biophysical mechanism for L1CAM-driven directional motility through asymmetric grip/slip states generating traction force on laminin, with disruption in an L1CAM-syndrome patient.","evidence":"Single-molecule imaging on growth cones, traction force microscopy, laminin vs polylysine comparison, patient-derived cells","pmids":["29483251"],"confidence":"High","gaps":["Molecular clutch components linking L1 to substrate not fully identified","How disease mutation alters grip/slip mechanistically not detailed"]},{"year":2018,"claim":"Linked L1CAM to cellular senescence, induced by TGFbeta and p16INK4a and repressed by RAS/MAPK, conferring increased adhesion and migration on senescent cells.","evidence":"Senescent-cell proteome profiling, pharmacological senescence induction, TGFbeta/Ras/p16 modulation, adhesion/migration assays","pmids":["29615539"],"confidence":"Medium","gaps":["Functional consequence of senescent L1CAM in vivo unknown","Transcriptional mechanism of induction not resolved"]},{"year":2019,"claim":"Showed FNIII-domain conformation gates ADAM10 shedding and that shedding is specifically required for myelination, dissociating it from axonal outgrowth and ventricular development.","evidence":"Zebrafish l1camb knockdown with proteinase-resistant and soluble L1cam rescue variants, in vivo phenotyping","pmids":["30842511"],"confidence":"High","gaps":["Mammalian validation of the myelination-specific requirement not shown here","Target receptor of shed L1 in myelination not identified"]},{"year":2019,"claim":"Identified a transmembrane-less L1CAM isoform (L1-deltaTM) generated by NOVA2-mediated exon skipping that drives angiogenesis via FGFR1.","evidence":"Splicing analysis, NOVA2 manipulation, direct NOVA2-pre-mRNA binding, FGFR1 inhibition, in vivo angiogenesis and tumor vasculature analysis","pmids":["30829570"],"confidence":"High","gaps":["Quantitative contribution of L1-deltaTM vs shed ectodomain to FGFR1 activation not separated","Regulation of NOVA2 in tumors not defined"]},{"year":2019,"claim":"Demonstrated L1CAM-decorated exosomes promote glioblastoma motility, proliferation, and invasion through FAK and FGFR, extending L1CAM signaling to extracellular vesicle delivery.","evidence":"Exosome isolation/characterization, motility and cell-cycle assays, chick embryo invasion model, FAK and FGFR inhibitors","pmids":["31426278"],"confidence":"Medium","gaps":["Direct exosomal L1-receptor engagement not biochemically shown","In vivo mammalian tumor relevance untested"]},{"year":2021,"claim":"Established that L1CAM drives ovarian cancer stemness and tumor initiation by physically binding and activating FGFR1, triggering SRC-mediated STAT3 activation.","evidence":"L1CAM-FGFR1 Co-IP, STAT3 inhibition rescue, gain/loss in patient-derived cancer stem cells, in vivo tumor initiation, neutralizing antibody","pmids":["34645505"],"confidence":"High","gaps":["Structural basis of L1-FGFR1 complex not resolved","Whether membrane vs soluble L1 drives this axis not separated"]},{"year":2021,"claim":"Linked N-glycosylation (via CWH43) to L1CAM lipid-microdomain association, plasmin cleavage susceptibility, CSF shedding, and nuclear translocation, tying glycosylation to signaling output.","evidence":"CWH43-deletion mice and HeLa cells, glycosylation and microdomain analysis, plasmin cleavage, CSF L1CAM, nuclear translocation assays","pmids":["34380733"],"confidence":"Medium","gaps":["Direct effect of glycosylation on specific adhesion/signaling interactions not dissected","Physiological significance of CSF shedding changes unclear"]},{"year":2022,"claim":"Showed L1CAM enables early dissemination of fallopian tube carcinoma precursors by upregulating integrins/fibronectin and activating AKT/ERK to support anchorage-independent survival and cohesive ovarian invasion.","evidence":"Gain/loss-of-function in fallopian tube secretory cells, tumor-ovary co-culture invasion model, AKT/ERK readouts, anchorage-independent survival assays","pmids":["36509990"],"confidence":"Medium","gaps":["Receptor mediating integrin/fibronectin upregulation not defined","In vivo human metastatic relevance not directly tested"]},{"year":2023,"claim":"Identified alpha-synuclein as a stabilizer of L1CAM that protects it from lysosomal degradation, increasing surface L1CAM and melanoma motility independent of transcription.","evidence":"SNCA CRISPR knockout and overexpression, motility and lysosomal degradation assays, mRNA/protein analysis","pmids":["37286800"],"confidence":"Medium","gaps":["Whether alpha-synuclein binds L1CAM directly not established","Mechanism diverting L1CAM from lysosomes not defined"]},{"year":2024,"claim":"Mapped a transcriptional control axis in which TRIM27 ubiquitinates and inactivates the L1CAM repressor KLF12, derepressing L1CAM to drive cisplatin resistance and metastasis.","evidence":"ChIP showing KLF12 binding to the L1CAM promoter, K326 ubiquitination mapping, L1CAM-depletion rescue, cisplatin resistance and metastasis assays","pmids":["38924996"],"confidence":"Medium","gaps":["Whether K33-linked ubiquitination is the sole mode of KLF12 regulation unclear","Generality beyond esophageal squamous cell carcinoma untested"]},{"year":2024,"claim":"Defined an ADAMTS1-L1CAM-EGFR signaling axis driving EMT and lymph node metastasis in oral squamous cell carcinoma.","evidence":"ADAMTS1 knockdown/overexpression in OSCC and xenografts, in vivo lymph node metastasis, EGFR/EMT marker analysis, apigenin inhibition","pmids":["38263290"],"confidence":"Medium","gaps":["Mechanism by which ADAMTS1 raises L1CAM levels not defined","Direct L1CAM-EGFR engagement not biochemically confirmed in this context"]},{"year":null,"claim":"How distinct L1CAM signaling modes (membrane adhesion, soluble ectodomain ligand activity, exosomal display, and nuclear L1-ICD) are coordinated and selectively engaged in development versus cancer remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model of L1CAM-receptor complexes (FGFR1, EGFR, integrins)","Context-specific switching between adhesion and ligand/signaling roles not defined","Tissue-specific regulation of shedding and isoform choice incompletely mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[23,19,26]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[9,11,14]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[4,5]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,8,21]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2,16]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[8]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[9,11]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,17,10,7]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,14,12,6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3,24,25]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[5,17,27]}],"complexes":[],"partners":["ADAM10","FGFR1","EGFR","ITGA5","ANK2","MAP2","NRP1","SNCA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P32004","full_name":"Neural cell adhesion molecule L1","aliases":[],"length_aa":1257,"mass_kda":140.0,"function":"Neural cell adhesion molecule involved in the dynamics of cell adhesion and in the generation of transmembrane signals at tyrosine kinase receptors. During brain development, critical in multiple processes, including neuronal migration, axonal growth and fasciculation, and synaptogenesis. In the mature brain, plays a role in the dynamics of neuronal structure and function, including synaptic plasticity","subcellular_location":"Cell membrane; Cell projection, growth cone; Cell projection, axon; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/P32004/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/L1CAM","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/L1CAM","total_profiled":1310},"omim":[{"mim_id":"615575","title":"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 6; HMND6","url":"https://www.omim.org/entry/615575"},{"mim_id":"609145","title":"NEUROFASCIN; NFASC","url":"https://www.omim.org/entry/609145"},{"mim_id":"608533","title":"F-BOX ONLY PROTEIN 38; FBXO38","url":"https://www.omim.org/entry/608533"},{"mim_id":"607416","title":"CELL ADHESION MOLECULE L1-LIKE; CHL1","url":"https://www.omim.org/entry/607416"},{"mim_id":"604865","title":"KLF TRANSCRIPTION FACTOR 7; KLF7","url":"https://www.omim.org/entry/604865"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":133.9},{"tissue":"intestine","ntpm":47.5}],"url":"https://www.proteinatlas.org/search/L1CAM"},"hgnc":{"alias_symbol":["CD171","NCAM-L1","CAML1"],"prev_symbol":["HSAS1","SPG1","HSAS","MASA","MIC5","S10"]},"alphafold":{"accession":"P32004","domains":[{"cath_id":"2.60.40.10","chopping":"33-133","consensus_level":"high","plddt":88.0889,"start":33,"end":133},{"cath_id":"2.60.40.10","chopping":"141-237","consensus_level":"medium","plddt":85.7235,"start":141,"end":237},{"cath_id":"2.60.40.10","chopping":"425-510","consensus_level":"high","plddt":91.1053,"start":425,"end":510},{"cath_id":"2.60.40.10","chopping":"520-610","consensus_level":"high","plddt":86.8053,"start":520,"end":610},{"cath_id":"2.60.40.10","chopping":"618-709","consensus_level":"high","plddt":85.981,"start":618,"end":709},{"cath_id":"2.60.40.10","chopping":"720-807","consensus_level":"high","plddt":90.862,"start":720,"end":807},{"cath_id":"2.60.40.10","chopping":"819-859_867-914","consensus_level":"medium","plddt":88.4693,"start":819,"end":914}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P32004","model_url":"https://alphafold.ebi.ac.uk/files/AF-P32004-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P32004-F1-predicted_aligned_error_v6.png","plddt_mean":78.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=L1CAM","jax_strain_url":"https://www.jax.org/strain/search?query=L1CAM"},"sequence":{"accession":"P32004","fasta_url":"https://rest.uniprot.org/uniprotkb/P32004.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P32004/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P32004"}},"corpus_meta":[{"pmid":"7920659","id":"PMC_7920659","title":"X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene.","date":"1994","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7920659","citation_count":347,"is_preprint":false},{"pmid":"22796939","id":"PMC_22796939","title":"L1CAM: a major driver for tumor cell invasion and motility.","date":"2012","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/22796939","citation_count":187,"is_preprint":false},{"pmid":"17699774","id":"PMC_17699774","title":"Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17699774","citation_count":175,"is_preprint":false},{"pmid":"26111503","id":"PMC_26111503","title":"L1CAM in human cancer.","date":"2015","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26111503","citation_count":150,"is_preprint":false},{"pmid":"1769655","id":"PMC_1769655","title":"Molecular structure and functional testing of human L1CAM: an interspecies comparison.","date":"1991","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1769655","citation_count":148,"is_preprint":false},{"pmid":"11438988","id":"PMC_11438988","title":"Genetic and clinical aspects of X-linked hydrocephalus (L1 disease): Mutations in the L1CAM gene.","date":"2001","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/11438988","citation_count":147,"is_preprint":false},{"pmid":"21297581","id":"PMC_21297581","title":"L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21297581","citation_count":145,"is_preprint":false},{"pmid":"9742395","id":"PMC_9742395","title":"Byr4 and Cdc16 form a two-component GTPase-activating protein for the Spg1 GTPase that controls septation in fission yeast.","date":"1998","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9742395","citation_count":143,"is_preprint":false},{"pmid":"20237819","id":"PMC_20237819","title":"L1CAM malfunction in the nervous system and human carcinomas.","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20237819","citation_count":124,"is_preprint":false},{"pmid":"12957823","id":"PMC_12957823","title":"The L1CAM extracellular region: a multi-domain protein with modular and cooperative binding modes.","date":"2003","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/12957823","citation_count":116,"is_preprint":false},{"pmid":"19144458","id":"PMC_19144458","title":"L1 cell adhesion molecule (L1CAM) in invasive tumors.","date":"2009","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/19144458","citation_count":110,"is_preprint":false},{"pmid":"35492832","id":"PMC_35492832","title":"L1CAM-associated extracellular vesicles: A systematic review of nomenclature, sources, separation, and characterization.","date":"2022","source":"Journal of extracellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35492832","citation_count":96,"is_preprint":false},{"pmid":"20162456","id":"PMC_20162456","title":"Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma.","date":"2010","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20162456","citation_count":90,"is_preprint":false},{"pmid":"19260824","id":"PMC_19260824","title":"Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.","date":"2009","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19260824","citation_count":89,"is_preprint":false},{"pmid":"27390347","id":"PMC_27390347","title":"Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility.","date":"2016","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/27390347","citation_count":87,"is_preprint":false},{"pmid":"18847309","id":"PMC_18847309","title":"L1-CAM in cancerous tissues.","date":"2008","source":"Expert opinion on biological therapy","url":"https://pubmed.ncbi.nlm.nih.gov/18847309","citation_count":85,"is_preprint":false},{"pmid":"15905095","id":"PMC_15905095","title":"Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity.","date":"2005","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/15905095","citation_count":85,"is_preprint":false},{"pmid":"27505134","id":"PMC_27505134","title":"L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.","date":"2016","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27505134","citation_count":81,"is_preprint":false},{"pmid":"32236821","id":"PMC_32236821","title":"Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease.","date":"2020","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/32236821","citation_count":81,"is_preprint":false},{"pmid":"16506207","id":"PMC_16506207","title":"The adhesion molecule L1 (CD171) promotes melanoma progression.","date":"2006","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16506207","citation_count":76,"is_preprint":false},{"pmid":"38868956","id":"PMC_38868956","title":"Single-extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron-derived EVs.","date":"2024","source":"Journal of extracellular vesicles","url":"https://pubmed.ncbi.nlm.nih.gov/38868956","citation_count":75,"is_preprint":false},{"pmid":"27267927","id":"PMC_27267927","title":"L1CAM: Cell adhesion and more.","date":"2016","source":"Progress in histochemistry and cytochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27267927","citation_count":67,"is_preprint":false},{"pmid":"21195665","id":"PMC_21195665","title":"Linking L1CAM-mediated signaling to NF-κB activation.","date":"2010","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21195665","citation_count":60,"is_preprint":false},{"pmid":"31500597","id":"PMC_31500597","title":"CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing.","date":"2019","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31500597","citation_count":56,"is_preprint":false},{"pmid":"31426278","id":"PMC_31426278","title":"Exosomal L1CAM Stimulates Glioblastoma Cell Motility, Proliferation, and Invasiveness.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31426278","citation_count":54,"is_preprint":false},{"pmid":"30829570","id":"PMC_30829570","title":"A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30829570","citation_count":54,"is_preprint":false},{"pmid":"26478212","id":"PMC_26478212","title":"L1-CAM and N-CAM: From Adhesion Proteins to Pharmacological Targets.","date":"2015","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26478212","citation_count":53,"is_preprint":false},{"pmid":"22370595","id":"PMC_22370595","title":"Role of L1CAM for axon sprouting and branching.","date":"2012","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/22370595","citation_count":51,"is_preprint":false},{"pmid":"16597699","id":"PMC_16597699","title":"MAP kinase pathway-dependent phosphorylation of the L1-CAM ankyrin binding site regulates neuronal growth.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16597699","citation_count":51,"is_preprint":false},{"pmid":"23212305","id":"PMC_23212305","title":"L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor.","date":"2012","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/23212305","citation_count":49,"is_preprint":false},{"pmid":"19953645","id":"PMC_19953645","title":"An updated and upgraded L1CAM mutation database.","date":"2010","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19953645","citation_count":49,"is_preprint":false},{"pmid":"30842511","id":"PMC_30842511","title":"L1cam-mediated developmental processes of the nervous system are differentially regulated by proteolytic processing.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30842511","citation_count":48,"is_preprint":false},{"pmid":"34645505","id":"PMC_34645505","title":"L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/34645505","citation_count":44,"is_preprint":false},{"pmid":"16400320","id":"PMC_16400320","title":"L1 (CD171) is highly expressed in gastrointestinal stromal tumors.","date":"2006","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/16400320","citation_count":43,"is_preprint":false},{"pmid":"11857550","id":"PMC_11857550","title":"Hydrocephalus and intestinal aganglionosis: is L1CAM a modifier gene in Hirschsprung disease?","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11857550","citation_count":42,"is_preprint":false},{"pmid":"15706405","id":"PMC_15706405","title":"Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens.","date":"2005","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/15706405","citation_count":42,"is_preprint":false},{"pmid":"20044598","id":"PMC_20044598","title":"L1-CAM as a target for treatment of cancer with monoclonal antibodies.","date":"2009","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20044598","citation_count":41,"is_preprint":false},{"pmid":"32429448","id":"PMC_32429448","title":"Different Shades of L1CAM in the Pathophysiology of Cancer Stem Cells.","date":"2020","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32429448","citation_count":41,"is_preprint":false},{"pmid":"25308870","id":"PMC_25308870","title":"Matrix RGD ligand density and L1CAM-mediated Schwann cell interactions synergistically enhance neurite outgrowth.","date":"2014","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/25308870","citation_count":40,"is_preprint":false},{"pmid":"27867005","id":"PMC_27867005","title":"Temporal expression of CD184(CXCR4) and CD171(L1CAM) identifies distinct early developmental stages of human retinal ganglion cells in embryonic stem cell derived retina.","date":"2016","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/27867005","citation_count":38,"is_preprint":false},{"pmid":"32588424","id":"PMC_32588424","title":"Recent insights into the role of L1CAM in cancer initiation and progression.","date":"2020","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32588424","citation_count":38,"is_preprint":false},{"pmid":"22503709","id":"PMC_22503709","title":"L1CAM increases MAP2 expression via the MAPK pathway to promote neurite outgrowth.","date":"2012","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/22503709","citation_count":38,"is_preprint":false},{"pmid":"18931829","id":"PMC_18931829","title":"Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration.","date":"2008","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/18931829","citation_count":37,"is_preprint":false},{"pmid":"18332088","id":"PMC_18332088","title":"L1 cell adhesion molecule (L1CAM) as a pathogenetic factor in endometriosis.","date":"2008","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18332088","citation_count":34,"is_preprint":false},{"pmid":"26883759","id":"PMC_26883759","title":"Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation.","date":"2016","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/26883759","citation_count":34,"is_preprint":false},{"pmid":"20811670","id":"PMC_20811670","title":"Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.","date":"2010","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/20811670","citation_count":33,"is_preprint":false},{"pmid":"32296437","id":"PMC_32296437","title":"Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4+ CAR T Cell Efficacy.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32296437","citation_count":32,"is_preprint":false},{"pmid":"25510351","id":"PMC_25510351","title":"L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor.","date":"2014","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25510351","citation_count":31,"is_preprint":false},{"pmid":"20696247","id":"PMC_20696247","title":"L1cam acts as a modifier gene during enteric nervous system development.","date":"2010","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/20696247","citation_count":31,"is_preprint":false},{"pmid":"27091730","id":"PMC_27091730","title":"Proteome analysis identifies L1CAM/CD171 and DPP4/CD26 as novel markers of human skin mast cells.","date":"2016","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/27091730","citation_count":30,"is_preprint":false},{"pmid":"30235708","id":"PMC_30235708","title":"Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic brain tumors.","date":"2018","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30235708","citation_count":30,"is_preprint":false},{"pmid":"28939985","id":"PMC_28939985","title":"L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.","date":"2017","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/28939985","citation_count":30,"is_preprint":false},{"pmid":"12834484","id":"PMC_12834484","title":"Adhesion molecules CD171 (L1CAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas).","date":"2003","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12834484","citation_count":29,"is_preprint":false},{"pmid":"28751757","id":"PMC_28751757","title":"Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.","date":"2017","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28751757","citation_count":29,"is_preprint":false},{"pmid":"33897875","id":"PMC_33897875","title":"Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33897875","citation_count":29,"is_preprint":false},{"pmid":"22815787","id":"PMC_22815787","title":"L1CAM binds ErbB receptors through Ig-like domains coupling cell adhesion and neuregulin signalling.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22815787","citation_count":28,"is_preprint":false},{"pmid":"1684949","id":"PMC_1684949","title":"Physical mapping of the loci Gabra3, DXPas8, CamL1, and Rsvp in a region of the mouse X chromosome homologous to human Xq28.","date":"1991","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1684949","citation_count":27,"is_preprint":false},{"pmid":"10196225","id":"PMC_10196225","title":"Regions of Byr4, a regulator of septation in fission yeast, that bind Spg1 or Cdc16 and form a two-component GTPase-activating protein with Cdc16.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10196225","citation_count":27,"is_preprint":false},{"pmid":"27695947","id":"PMC_27695947","title":"L1CAM: amending the \"low-risk\" category in endometrial carcinoma.","date":"2016","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27695947","citation_count":27,"is_preprint":false},{"pmid":"25641508","id":"PMC_25641508","title":"The role of L1cam in murine corticogenesis, and the pathogenesis of hydrocephalus.","date":"2015","source":"Pathology international","url":"https://pubmed.ncbi.nlm.nih.gov/25641508","citation_count":25,"is_preprint":false},{"pmid":"20225255","id":"PMC_20225255","title":"\"CRASH\"ing with the worm: insights into L1CAM functions and mechanisms.","date":"2010","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/20225255","citation_count":25,"is_preprint":false},{"pmid":"28504692","id":"PMC_28504692","title":"Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth.","date":"2017","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/28504692","citation_count":25,"is_preprint":false},{"pmid":"26770450","id":"PMC_26770450","title":"miR-503 inhibits cell proliferation and invasion in glioma by targeting L1CAM.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26770450","citation_count":25,"is_preprint":false},{"pmid":"20459551","id":"PMC_20459551","title":"Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets?","date":"2010","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/20459551","citation_count":25,"is_preprint":false},{"pmid":"9643285","id":"PMC_9643285","title":"A silent mutation, C924T (G308G), in the L1CAM gene results in X linked hydrocephalus (HSAS).","date":"1998","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9643285","citation_count":25,"is_preprint":false},{"pmid":"29483251","id":"PMC_29483251","title":"Grip and slip of L1-CAM on adhesive substrates direct growth cone haptotaxis.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29483251","citation_count":24,"is_preprint":false},{"pmid":"18386459","id":"PMC_18386459","title":"L1 (CAM) (CD171) in ovarian serous neoplasms.","date":"2008","source":"European journal of gynaecological oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18386459","citation_count":23,"is_preprint":false},{"pmid":"31504653","id":"PMC_31504653","title":"Mutations in MAGEL2 and L1CAM Are Associated With Congenital Hypopituitarism and Arthrogryposis.","date":"2019","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31504653","citation_count":23,"is_preprint":false},{"pmid":"33228199","id":"PMC_33228199","title":"Wnt/β-Catenin Target Genes in Colon Cancer Metastasis: The Special Case of L1CAM.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33228199","citation_count":23,"is_preprint":false},{"pmid":"38898558","id":"PMC_38898558","title":"Isolation and quantification of L1CAM-positive extracellular vesicles on a chip as a potential biomarker for Parkinson's Disease.","date":"2024","source":"Journal of extracellular vesicles","url":"https://pubmed.ncbi.nlm.nih.gov/38898558","citation_count":22,"is_preprint":false},{"pmid":"17640175","id":"PMC_17640175","title":"Neurotrophins 3 and 4 differentially regulate NCAM, L1 and N-cadherin expression during peripheral nerve regeneration.","date":"2008","source":"Biotechnology and applied biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17640175","citation_count":22,"is_preprint":false},{"pmid":"24489698","id":"PMC_24489698","title":"L1cam is crucial for cell locomotion and terminal translocation of the Soma in radial migration during murine corticogenesis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24489698","citation_count":22,"is_preprint":false},{"pmid":"36231047","id":"PMC_36231047","title":"Functional Diversity of Neuronal Cell Adhesion and Recognition Molecule L1CAM through Proteolytic Cleavage.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36231047","citation_count":19,"is_preprint":false},{"pmid":"9638658","id":"PMC_9638658","title":"Byr4, a dosage-dependent regulator of cytokinesis in S. pombe, interacts with a possible small GTPase pathway including Spg1 and Cdc16.","date":"1998","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/9638658","citation_count":19,"is_preprint":false},{"pmid":"21541352","id":"PMC_21541352","title":"Full-length L1CAM and not its Δ2Δ27 splice variant promotes metastasis through induction of gelatinase expression.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21541352","citation_count":19,"is_preprint":false},{"pmid":"37286800","id":"PMC_37286800","title":"Knocking out alpha-synuclein in melanoma cells downregulates L1CAM and decreases motility.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37286800","citation_count":18,"is_preprint":false},{"pmid":"38460672","id":"PMC_38460672","title":"L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.","date":"2024","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/38460672","citation_count":18,"is_preprint":false},{"pmid":"20940017","id":"PMC_20940017","title":"L1CAM ubiquitination facilitates its lysosomal degradation.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20940017","citation_count":18,"is_preprint":false},{"pmid":"37042019","id":"PMC_37042019","title":"L1CAM immunocapture generates a unique extracellular vesicle population with a reproducible miRNA fingerprint.","date":"2023","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/37042019","citation_count":17,"is_preprint":false},{"pmid":"24166603","id":"PMC_24166603","title":"The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors.","date":"2013","source":"Polish journal of pathology : official journal of the Polish Society of Pathologists","url":"https://pubmed.ncbi.nlm.nih.gov/24166603","citation_count":16,"is_preprint":false},{"pmid":"15225093","id":"PMC_15225093","title":"L1 (CD171) as a novel biomarker for ovarian and endometrial carcinomas.","date":"2004","source":"Expert review of molecular diagnostics","url":"https://pubmed.ncbi.nlm.nih.gov/15225093","citation_count":16,"is_preprint":false},{"pmid":"28134764","id":"PMC_28134764","title":"The Pleiotropic Role of L1CAM in Tumor Vasculature.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28134764","citation_count":16,"is_preprint":false},{"pmid":"32128973","id":"PMC_32128973","title":"A novel nonsense mutation in the L1CAM gene responsible for X-linked congenital hydrocephalus.","date":"2020","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32128973","citation_count":16,"is_preprint":false},{"pmid":"29615539","id":"PMC_29615539","title":"Induction, regulation and roles of neural adhesion molecule L1CAM in cellular senescence.","date":"2018","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/29615539","citation_count":16,"is_preprint":false},{"pmid":"38263290","id":"PMC_38263290","title":"Cyclic increase in the ADAMTS1-L1CAM-EGFR axis promotes the EMT and cervical lymph node metastasis of oral squamous cell carcinoma.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38263290","citation_count":16,"is_preprint":false},{"pmid":"36509990","id":"PMC_36509990","title":"L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/36509990","citation_count":16,"is_preprint":false},{"pmid":"38924996","id":"PMC_38924996","title":"KLF12 interacts with TRIM27 to affect cisplatin resistance and cancer metastasis in esophageal squamous cell carcinoma by regulating L1CAM expression.","date":"2024","source":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/38924996","citation_count":15,"is_preprint":false},{"pmid":"40210837","id":"PMC_40210837","title":"Most L1CAM Is not Associated with Extracellular Vesicles in Human Biofluids and iPSC-Derived Neurons.","date":"2025","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/40210837","citation_count":15,"is_preprint":false},{"pmid":"33872388","id":"PMC_33872388","title":"High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.","date":"2021","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33872388","citation_count":15,"is_preprint":false},{"pmid":"29152102","id":"PMC_29152102","title":"L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29152102","citation_count":15,"is_preprint":false},{"pmid":"36768928","id":"PMC_36768928","title":"Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36768928","citation_count":15,"is_preprint":false},{"pmid":"28625395","id":"PMC_28625395","title":"L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.","date":"2017","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28625395","citation_count":14,"is_preprint":false},{"pmid":"38542381","id":"PMC_38542381","title":"Chicoric Acid Ameliorated Beta-Amyloid Pathology and Enhanced Expression of Synaptic-Function-Related Markers via L1CAM in Alzheimer's Disease Models.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38542381","citation_count":14,"is_preprint":false},{"pmid":"30557309","id":"PMC_30557309","title":"L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30557309","citation_count":14,"is_preprint":false},{"pmid":"36963389","id":"PMC_36963389","title":"Viral delivery of L1CAM promotes axonal extensions by embryonic cerebral grafts in mouse brain.","date":"2023","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36963389","citation_count":13,"is_preprint":false},{"pmid":"32971459","id":"PMC_32971459","title":"L1cam curbs the differentiation of adult-born hippocampal neurons.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32971459","citation_count":13,"is_preprint":false},{"pmid":"30251576","id":"PMC_30251576","title":"L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters.","date":"2018","source":"International journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30251576","citation_count":13,"is_preprint":false},{"pmid":"34380733","id":"PMC_34380733","title":"Increased plasmin-mediated proteolysis of L1CAM in a mouse model of idiopathic normal pressure hydrocephalus.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34380733","citation_count":13,"is_preprint":false},{"pmid":"1964443","id":"PMC_1964443","title":"Linkage of a gene for neural cell adhesion molecule, L1 (CamL1) to the Rsvp region of the mouse X chromosome.","date":"1990","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1964443","citation_count":12,"is_preprint":false},{"pmid":"35429348","id":"PMC_35429348","title":"L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma.","date":"2022","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35429348","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48202,"output_tokens":7446,"usd":0.128148,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16999,"output_tokens":7960,"usd":0.141997,"stage2_stop_reason":"end_turn"},"total_usd":0.270145,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"Mutations in the L1CAM gene cause X-linked hydrocephalus (HSAS), MASA syndrome, and SPG1, demonstrating that L1CAM protein function is essential for nervous system development; two HSAS mutations were identified that abolish cell surface expression of L1CAM, representing functional null mutations.\",\n      \"method\": \"Mutational analysis in patient cohorts; functional assessment of cell surface expression loss\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated across multiple disease families, multiple orthogonal methods (sequencing + functional cell surface expression assessment), independently confirmed in subsequent studies\",\n      \"pmids\": [\"7920659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"L1CAM undergoes sequential proteolytic processing: first, ADAM10 cleaves L1CAM at the membrane to generate an L1-32 fragment; then presenilin/gamma-secretase performs regulated intramembrane proteolysis to release a 28 kDa intracellular domain (L1-ICD) that translocates to the nucleus and mediates gene regulation. Inhibition of either ADAM10 or gamma-secretase blocks nuclear translocation and L1-dependent gene regulation.\",\n      \"method\": \"Dominant-negative PS1 overexpression, gamma-secretase inhibitors, fluorescence and biochemical fractionation, recombinant L1-ICD overexpression in carcinoma cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal methods (pharmacological inhibition, dominant-negative, biochemical fractionation, overexpression) in single lab establishing cleavage mechanism\",\n      \"pmids\": [\"19260824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"L1CAM regulates DNA damage checkpoint responses and radioresistance of glioblastoma stem cells through nuclear translocation of the L1-ICD, which upregulates NBS1 expression via c-Myc, thereby enhancing MRE11-RAD50-NBS1 (MRN) complex activity and ATM-Chk2 checkpoint signaling. Ectopic NBS1 expression rescued checkpoint activation lost upon L1CAM knockdown.\",\n      \"method\": \"RNA interference knockdown, ectopic NBS1 rescue experiments, checkpoint activation assays, nuclear translocation analysis in glioblastoma stem cells\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (RNAi, rescue, pathway analysis) in single lab with rigorous epistasis experiment\",\n      \"pmids\": [\"21297581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"L1CAM expression in colon cancer cells confers metastatic capacity and induces liver metastasis in a mouse spleen-injection model. ADAM10, identified as a novel beta-catenin-TCF target gene, cleaves the L1CAM extracellular domain and enhances metastasis. L1CAM induces a specific gene program in colon cancer cells also elevated in human colorectal carcinoma tissue.\",\n      \"method\": \"Stable transfection of L1CAM in colon cancer cells, in vivo mouse liver metastasis assay, ADAM10 overexpression, DNA microarray analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo and in vitro functional assays with multiple cell lines, replicated across conditions with mechanistic follow-up\",\n      \"pmids\": [\"17699774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MAP kinase pathway-dependent phosphorylation of the FIGQY motif in the L1CAM cytoplasmic domain regulates its interaction with ankyrin B, and this modulation of ankyrin binding controls L1CAM-mediated neuronal growth. MAP kinase pathway inhibitors block L1CAM-mediated neuronal growth, and this blockade is partially rescued by inhibitors of L1CAM-ankyrin binding.\",\n      \"method\": \"Intramolecular BRET reporter assay for FIGQY phosphorylation, MAP kinase pathway inhibitors, ankyrin binding inhibitors, neuronal growth assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — novel BRET-based reporter plus pharmacological epistasis, multiple orthogonal methods establishing phosphorylation-dependent ankyrin binding as regulatory mechanism\",\n      \"pmids\": [\"16597699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"L1CAM promotes neurite outgrowth by directly binding microtubule-associated protein 2c (MAP2c) via its intracellular domain (as shown by ELISA binding assay), and by enhancing MAP2 expression through the MAPK pathway. L1-deficient mice show reduced MAP2c levels; combined deficiency in both L1 and MAP2 reduces neurite outgrowth in vitro.\",\n      \"method\": \"ELISA binding assay (direct binding of MAP2c to L1 intracellular domain), co-immunoprecipitation of MAP2 isoforms with L1, L1-knockout mice, MAPK inhibitors, in vitro neurite outgrowth assays\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct in vitro binding assay plus co-IP plus genetic loss-of-function with clear phenotypic readout\",\n      \"pmids\": [\"22503709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"L1CAM physically binds ErbB receptors (including erbB1/EGFR) through Ig-like domains in its extracellular region, and this interaction enhances erbB receptor response to neuregulins. L1CAM-erbB binding was demonstrated in heterologous systems and in the mammalian developing brain.\",\n      \"method\": \"Co-immunoprecipitation in heterologous systems and developing brain tissue, binding domain mapping with Ig-like domain constructs\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP in multiple systems (heterologous + brain tissue) with functional neuregulin response assay, single lab\",\n      \"pmids\": [\"22815787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"L1cam acts as a modifier gene in enteric nervous system development: loss of L1cam combined with heterozygous Sox10 loss significantly increases the incidence of aganglionosis by perturbing neural crest cell migration in the gut and causing excessive neural crest cell death prior to gut entry. Sox10 regulates L1cam expression.\",\n      \"method\": \"Two-locus complementation genetic crosses (L1cam knockout × Ret, Gdnf, Sox10 heterozygotes), in vivo aganglionosis scoring, neural crest cell migration analysis, cell death quantification\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — classical genetic epistasis with two-locus complementation, rigorous in vivo phenotypic readout, mechanistic follow-up showing migration defects and cell death\",\n      \"pmids\": [\"20696247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"L1CAM is ubiquitinated at the plasma membrane and in early endosomes; mono-ubiquitination enhances its lysosomal degradation and regulates intracellular trafficking, thereby controlling L1CAM re-appearance at the cell surface.\",\n      \"method\": \"Biochemical ubiquitination assays, subcellular fractionation, lysosomal degradation inhibitors, trafficking analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct biochemical demonstration of ubiquitination plus lysosomal degradation assay, single lab\",\n      \"pmids\": [\"20940017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"L1CAM stimulates glioma cell motility and proliferation through fibroblast growth factor receptor (FGFR) activation. Soluble L1 ectodomain (L1LE) acts as a ligand for FGFR1 on glioma cells; dominant-negative FGFR1 or L1 peptide blocking L1-FGFR interaction abolished glioma cell migration; combined shutdown of L1 expression and FGFR activity completely terminated cell migration in vitro.\",\n      \"method\": \"Dominant-negative FGFR1, shRNA knockdown of L1, L1-FGFR interaction-blocking peptide, FGFR1 chemical inhibitor PD173074, time-lapse motility assays, cell cycle analysis\",\n      \"journal\": \"Clinical & experimental metastasis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (dominant-negative, RNAi, blocking peptide, chemical inhibitor) converging on L1-FGFR1 interaction as mechanistic basis, single lab\",\n      \"pmids\": [\"23212305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ADAM10-mediated shedding of L1cam is regulated by its fibronectin type III (FNIII) domains; specifically, the third FNIII domain maintains a conformation restricting access to the membrane-proximal cleavage site. Metalloproteinase-mediated shedding is required for efficient myelination but not for axonal outgrowth or ventricular system development, as shown by rescue experiments with proteinase-resistant and soluble L1cam variants in zebrafish.\",\n      \"method\": \"Zebrafish l1camb knockdown, rescue experiments with proteinase-resistant and soluble L1cam variants, in vivo axonal outgrowth and myelination phenotype analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-specific mutant rescue experiments in vivo with clear differential phenotypic readouts for distinct developmental processes\",\n      \"pmids\": [\"30842511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Endothelial cells express a novel L1CAM isoform (L1-ΔTM) lacking the transmembrane domain, generated by NOVA2 splicing factor-mediated skipping of the transmembrane domain exon. L1-ΔTM is secreted as a soluble protein that promotes angiogenesis through FGFR1 signaling via autocrine and paracrine activities.\",\n      \"method\": \"Alternative splicing analysis, NOVA2 knockdown/overexpression, direct NOVA2 binding to L1CAM pre-mRNA, FGFR1 inhibition assays, in vivo angiogenesis models, ovarian cancer vasculature analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic dissection of splicing regulation (direct NOVA2-pre-mRNA binding), functional FGFR1 signaling rescue assays, in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"30829570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"L1CAM promotes oncogenicity in esophageal squamous cell carcinoma by upregulating ezrin expression through activation of integrin α5β1/MAPK/ERK/AP1 signaling. L1CAM knockdown decreased cell growth, migration, and invasiveness, while overexpression had opposite effects; ezrin was identified as a key downstream effector.\",\n      \"method\": \"L1CAM knockdown and overexpression, in vitro and in vivo tumorigenesis assays, gene expression microarray/GSEA analysis, mechanistic pathway inhibition studies\",\n      \"journal\": \"Journal of molecular medicine (Berlin, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss and gain of function with in vivo validation plus pathway analysis, single lab\",\n      \"pmids\": [\"28939985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Fibroblast-expressed L1CAM, induced by Mint3-mediated HIF-1 activation, stimulates ERK signaling via integrin α5β1 in adjacent cancer cells, promoting cancer cell proliferation in a cell-cell contact-dependent manner and enhancing tumor growth in vivo.\",\n      \"method\": \"Mint3 depletion in mouse embryonic fibroblasts, co-injection tumor assays in mice, gene expression analysis, L1CAM knockdown, pathway inhibition\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro functional assays with mechanistic pathway placement, single lab\",\n      \"pmids\": [\"28504692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"L1CAM promotes ovarian cancer stemness and tumor initiation by physically interacting with and activating FGFR1, which in turn induces SRC-mediated STAT3 activation. STAT3 inhibition prevented L1CAM-dependent stemness and tumor initiation; an L1CAM-neutralizing antibody blocked these activities.\",\n      \"method\": \"Co-immunoprecipitation of L1CAM-FGFR1 complex, STAT3 inhibition rescue assays, gain/loss-of-function in patient-derived cancer stem cells, in vivo tumor initiation assays, antibody-mediated neutralization\",\n      \"journal\": \"Journal of experimental & clinical cancer research : CR\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein-protein interaction (Co-IP) plus epistatic rescue experiments plus in vivo validation with multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"34645505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Full-length L1CAM (FL-L1CAM), but not the tumor-associated splice variant lacking exons 2 and 27 (SV-L1CAM), promotes experimental lung and liver metastasis. FL-L1CAM correlates with increased invasive potential and elevated MMP-2 and MMP-9 expression and activity.\",\n      \"method\": \"Selective overexpression of each isoform in tumor cells, in vivo mouse metastasis assays (lung/liver), MMP activity assays (zymography), in vitro invasion assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific overexpression with in vivo metastasis assays and biochemical MMP activity measurement, single lab\",\n      \"pmids\": [\"21541352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CWH43 deletion decreases N-glycosylation of L1CAM, reduces its association with cell membrane lipid microdomains, increases L1CAM cleavage by plasmin, and increases shedding of cleaved L1CAM in cerebrospinal fluid. CWH43 deletion also decreased L1CAM nuclear translocation, suggesting decreased intracellular signaling.\",\n      \"method\": \"CWH43 mutant mice and human HeLa cells with CWH43 deletion, N-glycosylation analysis, lipid microdomain fractionation, plasmin cleavage assays, CSF L1CAM measurement, nuclear translocation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biochemical methods in both mouse model and human cells, single lab\",\n      \"pmids\": [\"34380733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"L1cam is required for cell locomotion in the intermediate zone and terminal translocation of the soma through the primitive cortical zone during radial migration in murine corticogenesis. L1cam-knockdown neurons showed decreased locomotion velocity, longer and more undulated leading processes, and decreased somal movement during terminal translocation.\",\n      \"method\": \"In utero electroporation of shRNA targeting L1cam, time-lapse analysis of neuronal migration in brain slices, quantitative curvature index analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo knockdown with live time-lapse imaging and quantitative phenotypic analysis, single lab\",\n      \"pmids\": [\"24489698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"L1CAM-decorated exosomes stimulate glioblastoma cell motility, proliferation, and invasiveness. The motility and proliferation-promoting effects of L1-decorated exosomes are reduced by inhibitors of focal adhesion kinase (FAK) and fibroblast growth factor receptor (FGFR), placing L1CAM action upstream of these kinases.\",\n      \"method\": \"Exosome isolation and L1CAM decoration characterization, SuperScratch motility assay, DNA cell cycle analysis, chick embryo brain tumor invasion model, FAK and FGFR chemical inhibitors\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional assays with inhibitor pathway placement, single lab, multiple cell systems tested\",\n      \"pmids\": [\"31426278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"L1CAM expression on tumor-derived endothelial cells is upregulated by TNF-α, IFN-γ, and TGF-β1. L1CAM on endothelium mediates selective tumor cell adhesion and transendothelial migration; antibodies to L1CAM and its ligand neuropilin-1 blocked tube formation and SDF-1β-induced transmigration of tumor endothelial cells.\",\n      \"method\": \"Cytokine stimulation of endothelial cells, anti-L1CAM and anti-neuropilin-1 antibody blocking assays, tube formation assay, transmigration assay, tumor cell adhesion to endothelial monolayers\",\n      \"journal\": \"Journal of molecular medicine (Berlin, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional blocking antibody experiments with multiple assays establishing L1CAM role in transendothelial migration, single lab\",\n      \"pmids\": [\"18931829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary: L1CAM upregulates integrins and fibronectin in malignant cells and activates AKT and ERK pathways, increasing cell survival under anchorage-independent conditions and enabling cohesive invasion of the ovary.\",\n      \"method\": \"L1CAM gain/loss-of-function in fallopian tube secretory cells, tumor-ovary co-culture invasion model, pathway analysis (AKT, ERK activation), anchorage-independent survival assays\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel co-culture model, genetic manipulation with multiple functional and signaling readouts, single lab\",\n      \"pmids\": [\"36509990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Alpha-synuclein promotes L1CAM expression and localization to the plasma membrane by protecting L1CAM from lysosomal degradation. Knockout of SNCA in melanoma cells led to a 75% reduction in motility and significant decreases in L1CAM and N-cadherin expression; the reduction in L1CAM was not due to transcriptional effects but rather increased lysosomal degradation of L1CAM.\",\n      \"method\": \"SNCA knockout by CRISPR in melanoma cell lines, stable SNCA overexpression in neuroblastoma cells, motility assays, lysosomal degradation assays, mRNA and protein expression analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss and gain of function with mechanistic follow-up (lysosomal degradation assay), single lab\",\n      \"pmids\": [\"37286800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"L1CAM is induced during cellular senescence by TGFβ signaling and is suppressed by RAS/MAPK(Erk) signaling; it is also induced by p16INK4a-mediated CDK inhibition. Senescent cells with enhanced surface L1CAM showed increased adhesion to extracellular matrix and faster migration.\",\n      \"method\": \"Proteome profiling of senescent cells, pharmacological induction of senescence, TGFβ treatment, Ras expression, p16INK4a modulation, cell adhesion and migration assays\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological and genetic perturbations with functional adhesion/migration readouts, single lab\",\n      \"pmids\": [\"29615539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"L1-CAM undergoes grip and slip states on adhesive substrates; the ratio of grip state is higher on laminin than on polylysine, accompanied by increased traction force. Asymmetric grip/slip of L1-CAM under the growth cone generates directional force for laminin-induced haptotaxis. This mechanism is disrupted in an L1CAM syndrome patient with corpus callosum agenesis.\",\n      \"method\": \"Single-molecule imaging of L1-CAM on growth cones, traction force microscopy, laminin vs polylysine substrate comparison, patient-derived cell analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — single-molecule imaging with traction force microscopy establishing biophysical mechanism, disease validation in patient cells\",\n      \"pmids\": [\"29483251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"KLF12 binds directly to the L1CAM promoter and represses its transcription; TRIM27 ubiquitinates KLF12 at K326 via K33-linked polyubiquitination, reducing KLF12 transcriptional activity and consequently increasing L1CAM expression. Depletion of L1CAM abrogates cisplatin resistance and cancer metastasis caused by KLF12 loss in esophageal squamous cell carcinoma.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) assay showing KLF12 binding to L1CAM promoter, ubiquitination site mapping (K326), rescue experiments with L1CAM depletion, cisplatin resistance and metastasis assays\",\n      \"journal\": \"Drug resistance updates\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP evidence for promoter binding, ubiquitination site identification, functional rescue, single lab\",\n      \"pmids\": [\"38924996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The ADAMTS1 metalloprotease activates an ADAMTS1-L1CAM-EGFR signaling axis in oral squamous cell carcinoma: ADAMTS1 increases L1CAM levels, which activates EGFR, leading to EMT and enhanced invasiveness and lymph node metastasis.\",\n      \"method\": \"ADAMTS1 knockdown and overexpression in OSCC cells and xenografts, in vivo lymph node metastasis assay, mechanistic pathway analysis (EGFR activation, EMT markers), pharmacological inhibition by apigenin\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo xenograft model with genetic manipulation and pathway analysis, single lab\",\n      \"pmids\": [\"38263290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Human L1CAM supports neurite growth in vitro and shows 92% amino acid identity to mouse L1cam. Comparison across species identifies the second Ig domain and second fibronectin type III domain as the most conserved and likely functionally important domains.\",\n      \"method\": \"Neurite growth assay on human L1CAM substrate, full coding region cloning and sequencing, cross-species sequence comparison\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional neurite growth assay combined with sequence analysis, foundational study\",\n      \"pmids\": [\"1769655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"L1cam deletion in adult hippocampal stem/progenitor cells increases differentiation of progenitors into new neurons, increases dendritic arbor complexity in immature neurons, and accelerates age-related decline in hippocampal neurogenesis; deletion in neurons leads to increased anxiety-related behavior.\",\n      \"method\": \"Conditional knockout using multiple Cre-driver lines in mice, BrdU/EdU lineage tracing, morphological analysis of dendritic complexity, behavioral assays\",\n      \"journal\": \"Stem cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional genetic deletion with multiple Cre lines and multiple readouts, single lab\",\n      \"pmids\": [\"32971459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A silent C924T mutation (G308G) in exon 8 of L1CAM creates a novel 5' splice site, resulting in an in-frame deletion of 69 bp (23 amino acids) from exon 8, causing X-linked hydrocephalus. RT-PCR of affected fetal RNA confirmed aberrant splicing.\",\n      \"method\": \"DNA sequencing, splice site consensus sequence analysis, RT-PCR of affected fetal RNA confirming in-frame deletion\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RT-PCR confirmation of predicted aberrant splicing in patient-derived RNA, establishing mechanism for a synonymous mutation\",\n      \"pmids\": [\"9643285\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"L1CAM is a multifunctional immunoglobulin superfamily cell adhesion molecule that mediates homophilic and heterophilic cell-cell adhesion through its extracellular Ig and fibronectin type III domains, binds ErbB receptors and FGFR to activate downstream MAPK/ERK and PI3K/AKT signaling, undergoes regulated intramembrane proteolysis by ADAM10 then presenilin/gamma-secretase to release a nuclear-signaling intracellular domain (L1-ICD) that upregulates target genes (including NBS1 via c-Myc), is regulated post-translationally by ubiquitination (promoting lysosomal degradation), MAP kinase-dependent FIGQY phosphorylation (controlling ankyrin B binding and cytoskeletal linkage), N-glycosylation (affecting lipid microdomain association and susceptibility to plasmin cleavage), and alpha-synuclein-dependent lysosomal trafficking; it promotes neuronal migration, axon growth, and myelination (with shedding specifically required for myelination but not axonal outgrowth), and in cancer drives invasion, metastasis, chemoresistance, and stemness primarily through integrin (α5β1, αvβ3/αvβ5), FGFR1, and EGFR signaling, with transcription regulated by Wnt/β-catenin-TCF, androgen receptor, KLF12/TRIM27, and TGFβ pathways.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"L1CAM is an immunoglobulin-superfamily cell adhesion molecule essential for nervous system development, where its function is required for neuronal migration, axon growth, and myelination, and whose loss-of-function mutations cause X-linked hydrocephalus, MASA syndrome, and SPG1 [#0, #17, #10]. At the growth cone, L1CAM transduces adhesion into directional motility through asymmetric grip/slip dynamics on laminin that generate traction force for haptotaxis [#23], and it couples to the cytoskeleton via MAP-kinase-dependent phosphorylation of its cytoplasmic FIGQY motif, which controls ankyrin B binding and neuronal growth, and via direct binding to MAP2c through its intracellular domain [#4, #5]. L1CAM is processed by sequential proteolysis: ADAM10 sheds the ectodomain and presenilin/gamma-secretase then liberates a nuclear L1-ICD that drives gene regulation, including upregulation of NBS1 via c-Myc to enhance MRN-dependent ATM-Chk2 checkpoint signaling and radioresistance [#1, #2]; this shedding, restricted by the third fibronectin type III domain, is specifically required for myelination but not axonal outgrowth [#10]. Surface levels of L1CAM are controlled post-translationally by mono-ubiquitination-driven lysosomal degradation, by N-glycosylation that governs lipid-microdomain association and plasmin susceptibility, and by alpha-synuclein-dependent protection from lysosomal turnover [#8, #16, #21]. In cancer, L1CAM and its shed/soluble ectodomain drive invasion, metastasis, stemness, and chemoresistance by acting as a ligand for FGFR1 (engaging SRC-STAT3 and FAK) and by activating integrin alpha5beta1 and EGFR signaling through ERK/AKT, with transcription regulated by beta-catenin-TCF-induced ADAM10, KLF12/TRIM27, ADAMTS1, and TGFbeta inputs [#3, #9, #14, #12, #24, #25].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established human L1CAM as a functional neurite-growth-promoting adhesion molecule and pinpointed the most conserved Ig and FNIII domains as candidate functional regions.\",\n      \"evidence\": \"Neurite growth assay on human L1CAM substrate plus cross-species sequence comparison\",\n      \"pmids\": [\"1769655\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not define the binding partners engaged by the conserved domains\", \"Functional importance inferred from conservation, not direct mutagenesis\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Demonstrated that L1CAM function is essential for human nervous system development by linking loss-of-function mutations to X-linked hydrocephalus, MASA, and SPG1.\",\n      \"evidence\": \"Mutational analysis in patient cohorts with functional cell-surface expression assays\",\n      \"pmids\": [\"7920659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which downstream molecular activities of L1CAM are lost in disease\", \"Genotype-phenotype relationships across syndromes not mechanistically explained\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed that even a synonymous coding change can disrupt L1CAM by creating a cryptic splice site, broadening the mutational mechanisms causing hydrocephalus.\",\n      \"evidence\": \"DNA sequencing and RT-PCR of affected fetal RNA confirming in-frame exon 8 deletion\",\n      \"pmids\": [\"9643285\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of the 23-amino-acid deletion on protein folding/adhesion not tested\", \"Single mutation; generalizability unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected extracellular signaling to cytoskeletal coupling by showing MAP-kinase-dependent FIGQY phosphorylation controls ankyrin B binding and thereby L1CAM-mediated neuronal growth.\",\n      \"evidence\": \"Intramolecular BRET phosphorylation reporter, MAP kinase and ankyrin-binding inhibitors, neuronal growth assays\",\n      \"pmids\": [\"16597699\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the kinase acting directly on FIGQY not established\", \"Rescue by ankyrin-binding inhibitors only partial, implying additional effectors\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placed L1CAM in a Wnt-driven metastatic program, identifying ADAM10 as a beta-catenin-TCF target that sheds L1CAM and enhances colon cancer liver metastasis.\",\n      \"evidence\": \"Stable L1CAM transfection, in vivo mouse liver metastasis, ADAM10 overexpression, microarray analysis\",\n      \"pmids\": [\"17699774\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The receptor(s) transducing the pro-metastatic L1CAM signal not defined here\", \"Causal contribution of shedding vs full-length L1CAM to metastasis not separated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Revealed an endothelial role for L1CAM in tumor vasculature, mediating tumor-cell adhesion and transendothelial migration via neuropilin-1.\",\n      \"evidence\": \"Cytokine stimulation, anti-L1CAM and anti-neuropilin-1 blocking antibodies, tube formation and transmigration assays\",\n      \"pmids\": [\"18931829\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct L1CAM-neuropilin-1 binding not biochemically demonstrated\", \"In vivo relevance to metastasis not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined the regulated intramembrane proteolysis cascade (ADAM10 then gamma-secretase) that releases a nuclear-signaling L1-ICD, establishing L1CAM as a source of nuclear gene-regulatory signaling.\",\n      \"evidence\": \"Dominant-negative PS1, gamma-secretase inhibitors, biochemical fractionation, recombinant L1-ICD overexpression in carcinoma cells\",\n      \"pmids\": [\"19260824\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of L1-ICD not identified in this study\", \"Mechanism of L1-ICD nuclear import not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated post-translational control of L1CAM surface availability through mono-ubiquitination-driven lysosomal degradation and trafficking.\",\n      \"evidence\": \"Biochemical ubiquitination assays, subcellular fractionation, lysosomal inhibitors, trafficking analysis\",\n      \"pmids\": [\"20940017\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The E3 ligase responsible was not identified\", \"Physiological/disease contexts regulating this turnover not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified L1cam as a Sox10-regulated modifier gene in enteric nervous system development, controlling neural crest migration and survival.\",\n      \"evidence\": \"Two-locus complementation crosses (L1cam x Sox10/Ret/Gdnf heterozygotes), aganglionosis scoring, migration and cell-death analysis\",\n      \"pmids\": [\"20696247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism linking L1cam to crest cell survival not defined\", \"Direct evidence for Sox10 acting on the L1cam promoter not shown here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected nuclear L1-ICD signaling to DNA-damage checkpoint control, showing it upregulates NBS1 via c-Myc to drive MRN/ATM-Chk2 signaling and radioresistance in glioblastoma stem cells.\",\n      \"evidence\": \"RNAi knockdown, ectopic NBS1 rescue, checkpoint activation assays in glioblastoma stem cells\",\n      \"pmids\": [\"21297581\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DNA binding of L1-ICD vs indirect action via c-Myc not fully resolved\", \"Generality beyond glioblastoma stem cells untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Distinguished isoform-specific oncogenic activity, showing full-length but not the exon-2/27-deleted splice variant promotes metastasis via elevated MMP-2/MMP-9.\",\n      \"evidence\": \"Isoform-specific overexpression, in vivo lung/liver metastasis assays, zymography, invasion assays\",\n      \"pmids\": [\"21541352\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which deleted exons abolish activity not defined\", \"Receptor coupling to MMP induction not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified FGFR1 as a receptor for the soluble L1 ectodomain driving glioma motility and proliferation, establishing a ligand-receptor mode of L1CAM action distinct from adhesion.\",\n      \"evidence\": \"Dominant-negative FGFR1, shRNA, L1-FGFR blocking peptide, PD173074, time-lapse motility and cell-cycle assays\",\n      \"pmids\": [\"23212305\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry/structure of the L1-FGFR1 interaction not defined\", \"Downstream signaling branches not fully mapped in this study\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed L1CAM physically binds ErbB/EGFR receptors via Ig domains and potentiates neuregulin responses, broadening its receptor crosstalk repertoire.\",\n      \"evidence\": \"Reciprocal Co-IP in heterologous systems and developing brain, Ig-domain mapping, neuregulin response assays\",\n      \"pmids\": [\"22815787\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence in vivo development not established\", \"Direct vs complex-mediated binding not fully resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated L1CAM promotes neurite outgrowth via direct intracellular binding to MAP2c and MAPK-dependent MAP2 induction, linking adhesion to microtubule organization.\",\n      \"evidence\": \"ELISA direct-binding assay, Co-IP, L1-knockout mice, MAPK inhibitors, neurite outgrowth assays\",\n      \"pmids\": [\"22503709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding interface on the L1 intracellular domain not mapped\", \"Relative contributions of direct binding vs MAP2 induction not quantified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined the cell-biological role of L1cam in radial migration, required for intermediate-zone locomotion and terminal somal translocation during corticogenesis.\",\n      \"evidence\": \"In utero electroporation of shRNA, time-lapse imaging in brain slices, quantitative morphometry\",\n      \"pmids\": [\"24489698\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular effectors coupling L1cam to soma movement not identified\", \"Single-gene knockdown; modifier interactions not examined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established integrin alpha5beta1/MAPK/ERK/AP1 as an L1CAM oncogenic pathway driving ezrin expression in esophageal squamous cell carcinoma.\",\n      \"evidence\": \"L1CAM knockdown/overexpression, in vitro/in vivo tumorigenesis, GSEA, pathway inhibition\",\n      \"pmids\": [\"28939985\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct L1CAM-integrin engagement not biochemically shown\", \"Role of ezrin as the sole effector not exclusive\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed a paracrine mechanism in which fibroblast-expressed L1CAM, driven by Mint3/HIF-1, stimulates integrin alpha5beta1/ERK signaling in adjacent cancer cells.\",\n      \"evidence\": \"Mint3 depletion in MEFs, co-injection tumor assays, L1CAM knockdown, pathway inhibition\",\n      \"pmids\": [\"28504692\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contact-dependent ligand-receptor identity not biochemically confirmed\", \"Relevance to human stromal contexts not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Provided biophysical mechanism for L1CAM-driven directional motility through asymmetric grip/slip states generating traction force on laminin, with disruption in an L1CAM-syndrome patient.\",\n      \"evidence\": \"Single-molecule imaging on growth cones, traction force microscopy, laminin vs polylysine comparison, patient-derived cells\",\n      \"pmids\": [\"29483251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular clutch components linking L1 to substrate not fully identified\", \"How disease mutation alters grip/slip mechanistically not detailed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked L1CAM to cellular senescence, induced by TGFbeta and p16INK4a and repressed by RAS/MAPK, conferring increased adhesion and migration on senescent cells.\",\n      \"evidence\": \"Senescent-cell proteome profiling, pharmacological senescence induction, TGFbeta/Ras/p16 modulation, adhesion/migration assays\",\n      \"pmids\": [\"29615539\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of senescent L1CAM in vivo unknown\", \"Transcriptional mechanism of induction not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed FNIII-domain conformation gates ADAM10 shedding and that shedding is specifically required for myelination, dissociating it from axonal outgrowth and ventricular development.\",\n      \"evidence\": \"Zebrafish l1camb knockdown with proteinase-resistant and soluble L1cam rescue variants, in vivo phenotyping\",\n      \"pmids\": [\"30842511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian validation of the myelination-specific requirement not shown here\", \"Target receptor of shed L1 in myelination not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified a transmembrane-less L1CAM isoform (L1-deltaTM) generated by NOVA2-mediated exon skipping that drives angiogenesis via FGFR1.\",\n      \"evidence\": \"Splicing analysis, NOVA2 manipulation, direct NOVA2-pre-mRNA binding, FGFR1 inhibition, in vivo angiogenesis and tumor vasculature analysis\",\n      \"pmids\": [\"30829570\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of L1-deltaTM vs shed ectodomain to FGFR1 activation not separated\", \"Regulation of NOVA2 in tumors not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated L1CAM-decorated exosomes promote glioblastoma motility, proliferation, and invasion through FAK and FGFR, extending L1CAM signaling to extracellular vesicle delivery.\",\n      \"evidence\": \"Exosome isolation/characterization, motility and cell-cycle assays, chick embryo invasion model, FAK and FGFR inhibitors\",\n      \"pmids\": [\"31426278\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct exosomal L1-receptor engagement not biochemically shown\", \"In vivo mammalian tumor relevance untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established that L1CAM drives ovarian cancer stemness and tumor initiation by physically binding and activating FGFR1, triggering SRC-mediated STAT3 activation.\",\n      \"evidence\": \"L1CAM-FGFR1 Co-IP, STAT3 inhibition rescue, gain/loss in patient-derived cancer stem cells, in vivo tumor initiation, neutralizing antibody\",\n      \"pmids\": [\"34645505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of L1-FGFR1 complex not resolved\", \"Whether membrane vs soluble L1 drives this axis not separated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked N-glycosylation (via CWH43) to L1CAM lipid-microdomain association, plasmin cleavage susceptibility, CSF shedding, and nuclear translocation, tying glycosylation to signaling output.\",\n      \"evidence\": \"CWH43-deletion mice and HeLa cells, glycosylation and microdomain analysis, plasmin cleavage, CSF L1CAM, nuclear translocation assays\",\n      \"pmids\": [\"34380733\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct effect of glycosylation on specific adhesion/signaling interactions not dissected\", \"Physiological significance of CSF shedding changes unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed L1CAM enables early dissemination of fallopian tube carcinoma precursors by upregulating integrins/fibronectin and activating AKT/ERK to support anchorage-independent survival and cohesive ovarian invasion.\",\n      \"evidence\": \"Gain/loss-of-function in fallopian tube secretory cells, tumor-ovary co-culture invasion model, AKT/ERK readouts, anchorage-independent survival assays\",\n      \"pmids\": [\"36509990\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating integrin/fibronectin upregulation not defined\", \"In vivo human metastatic relevance not directly tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified alpha-synuclein as a stabilizer of L1CAM that protects it from lysosomal degradation, increasing surface L1CAM and melanoma motility independent of transcription.\",\n      \"evidence\": \"SNCA CRISPR knockout and overexpression, motility and lysosomal degradation assays, mRNA/protein analysis\",\n      \"pmids\": [\"37286800\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether alpha-synuclein binds L1CAM directly not established\", \"Mechanism diverting L1CAM from lysosomes not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Mapped a transcriptional control axis in which TRIM27 ubiquitinates and inactivates the L1CAM repressor KLF12, derepressing L1CAM to drive cisplatin resistance and metastasis.\",\n      \"evidence\": \"ChIP showing KLF12 binding to the L1CAM promoter, K326 ubiquitination mapping, L1CAM-depletion rescue, cisplatin resistance and metastasis assays\",\n      \"pmids\": [\"38924996\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether K33-linked ubiquitination is the sole mode of KLF12 regulation unclear\", \"Generality beyond esophageal squamous cell carcinoma untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined an ADAMTS1-L1CAM-EGFR signaling axis driving EMT and lymph node metastasis in oral squamous cell carcinoma.\",\n      \"evidence\": \"ADAMTS1 knockdown/overexpression in OSCC and xenografts, in vivo lymph node metastasis, EGFR/EMT marker analysis, apigenin inhibition\",\n      \"pmids\": [\"38263290\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which ADAMTS1 raises L1CAM levels not defined\", \"Direct L1CAM-EGFR engagement not biochemically confirmed in this context\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How distinct L1CAM signaling modes (membrane adhesion, soluble ectodomain ligand activity, exosomal display, and nuclear L1-ICD) are coordinated and selectively engaged in development versus cancer remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model of L1CAM-receptor complexes (FGFR1, EGFR, integrins)\", \"Context-specific switching between adhesion and ligand/signaling roles not defined\", \"Tissue-specific regulation of shedding and isoform choice incompletely mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [23, 19, 26]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [9, 11, 14]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 8, 21]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2, 16]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [9, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 17, 10, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 14, 12, 6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3, 24, 25]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [5, 17, 27]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ADAM10\", \"FGFR1\", \"EGFR\", \"ITGA5\", \"ANK2\", \"MAP2\", \"NRP1\", \"SNCA\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}